{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:31:00Z","timestamp":1782390660934,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.seizure.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T21:19:35Z","timestamp":1649452775000},"page":"164-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis"],"prefix":"10.1016","volume":"99","author":[{"given":"Nagita","family":"Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Madaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2022.04.004_bib0001","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fneur.2014.00225","article-title":"Conceptualizing lennox-gastaut syndrome as a secondary network epilepsy","volume":"5","author":"Archer","year":"2014","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2022.04.004_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.03177.x","article-title":"Definition and natural history of Lennox-Gastaut syndrome","volume":"52","author":"Camfield","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.04.004_bib0003","series-title":"Lennox gastaut syndrome. in: statpearls. treasure island (FL): statpearls publishing copyright \u00a9 2021","author":"Amrutkar","year":"2021"},{"issue":"4","key":"10.1016\/j.seizure.2022.04.004_bib0004","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/epi4.12548","article-title":"Classifying etiology of infantile spasms syndrome in resource-limited settings: a study from the South Asian region","volume":"6","author":"Wanigasinghe","year":"2021","journal-title":"Epilepsia open"},{"issue":"1","key":"10.1016\/j.seizure.2022.04.004_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.seizure.2022.04.004_bib0006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpn.2018.09.010","article-title":"Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (\u22651 to <4 years old) with Lennox-Gastaut syndrome: final results from randomized study 303","volume":"23","author":"Arzimanoglou","year":"2019","journal-title":"Eur J Paediatric Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2022.04.004_bib0007","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1528-1167.2008.01935.x","article-title":"Clobazam in the treatment of Lennox-Gastaut syndrome","volume":"50","author":"Conry","year":"2009","journal-title":"Epilepsia"},{"issue":"20","key":"10.1016\/j.seizure.2022.04.004_bib0008","first-page":"1888","volume":"378","author":"Devinsky","year":"2018","journal-title":"Effect Cannabidiol Drop Seizures Lennox\u2013Gastaut Syndrome"},{"issue":"21","key":"10.1016\/j.seizure.2022.04.004_bib0009","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"issue":"25","key":"10.1016\/j.seizure.2022.04.004_bib0010","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group","volume":"337","author":"Motte","year":"1997","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.seizure.2022.04.004_bib0011","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.seizure.2022.04.004_bib0012","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.eplepsyres.2014.08.019","article-title":"Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan","volume":"108","author":"Ohtsuka","year":"2014","journal-title":"Epilepsy Res"},{"issue":"9","key":"10.1016\/j.seizure.2022.04.004_bib0013","first-page":"1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Topiramate YL Study Group. Neurology"},{"issue":"10125","key":"10.1016\/j.seizure.2022.04.004_bib0014","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2022.04.004_bib0015","doi-asserted-by":"crossref","unstructured":"Zhang L., Wang J., Wang C. Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis. Developmental medicine and child neurology. 2021.","DOI":"10.1111\/dmcn.15072"},{"issue":"9","key":"10.1016\/j.seizure.2022.04.004_bib0016","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.seizure.2022.04.004_bib0017","unstructured":"Higgins J.P., Savovic J., Page M.J., Sterne J.A. A revised tool to assess risk of bias in randomized trials (RoB 2). 2019; https:\/\/www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2."},{"key":"10.1016\/j.seizure.2022.04.004_bib0018","doi-asserted-by":"crossref","unstructured":"Conry J.A., Ng Y.-.T., Kernitsky L., et\u00a0al. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years. 2014;55(4):558\u201367.","DOI":"10.1111\/epi.12561"},{"issue":"S1","key":"10.1016\/j.seizure.2022.04.004_bib0019","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1528-1157.2000.tb02179.x","article-title":"Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial","volume":"41","author":"Glauser","year":"2000","journal-title":"Topiramate YL Study Group. Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2022.04.004_bib0020","first-page":"202","article-title":"Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term","volume":"122","author":"Kluger","year":"2010","journal-title":"Open-Label Extension Study"},{"key":"10.1016\/j.seizure.2022.04.004_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.01.002","article-title":"Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: an open-label study following a randomized clinical trial","volume":"121","author":"Ohtsuka","year":"2016","journal-title":"Epilepsy Res"},{"issue":"9","key":"10.1016\/j.seizure.2022.04.004_bib0022","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/epi.17000","article-title":"Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: results of a long-term open-label extension trial","volume":"62","author":"Patel","year":"2021","journal-title":"Epilepsia"},{"issue":"20","key":"10.1016\/j.seizure.2022.04.004_bib0024","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox\u2013gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2022.04.004_bib0025","series-title":"Cochrane Handbook for Systematic Reviews of Interventions [updated March 2011]: The Cochrane Collaboration","article-title":"Measures of relative effect: the risk ratio and odds ratio","author":"Deeks","year":"2011"},{"key":"10.1016\/j.seizure.2022.04.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106629","article-title":"Long-term epilepsy control, motor function, cognition, sleep and quality of life in children with West syndrome","volume":"173","author":"Bhanudeep","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2022.04.004_bib0027","first-page":"1","article-title":"Epilepsy and neurodevelopmental outcomes in a cohort of west syndrome beyond two years of age","author":"Aramanadka","year":"2021","journal-title":"Indian J Pediatr"},{"issue":"6","key":"10.1016\/j.seizure.2022.04.004_bib0028","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2147\/NDT.S1668","article-title":"Treatment of Lennox-Gastaut syndrome: overview and recent findings","volume":"4","author":"van Rijckevorsel","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.seizure.2022.04.004_bib0029","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.seizure.2021.06.020","article-title":"Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: an indirect treatment comparison","volume":"91","author":"Devi","year":"2021","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2022.04.004_bib0030","first-page":"45","article-title":"The efficacy and safety of zonisamide as an add-on drug in the treatment of lennox\u2013gastaut syndrome","volume":"4","author":"Fallah","year":"2011","journal-title":"Iran J Child Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2022.04.004_bib0031","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1528-1157.1994.tb02544.x","article-title":"Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study","volume":"35","author":"Feucht","year":"1994","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.seizure.2022.04.004_bib0032","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/088307380001500803","article-title":"Vagus nerve stimulation treatment for lennox-gastaut syndrome","volume":"15","author":"Hosain","year":"2000","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2022.04.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0449","article-title":"Long-term outcome of resective epilepsy surgery in patients with lennox-gastaut syndrome","volume":"142","author":"Kang","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.seizure.2022.04.004_bib0034","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.seizure.2018.09.019","article-title":"Sulthiame add-on therapy in children with Lennox-Gastaut syndrome: a study of 44 patients","volume":"62","author":"Caraballo","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2022.04.004_bib0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2019.12.012","article-title":"Open-label, uncontrolled retrospective study of perampanel in adults with Lennox-Gastaut syndrome","volume":"75","author":"Crespel","year":"2020","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2022.04.004_bib0036","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0887-8994(02)00461-7","article-title":"Nitrazepam for the treatment of Lennox-Gastaut syndrome","volume":"28","author":"Hosain","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2022.04.004_bib0037","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2015.10.009","article-title":"Efficacy and tolerability of add-on Lacosamide treatment in adults with Lennox-Gastaut syndrome: an observational study","volume":"33","author":"Andrade-Machado","year":"2015","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2022.04.004_bib0038","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1528-1167.2006.00430.x","article-title":"Extended, one-stage callosal section for treatment of refractory secondarily generalized epilepsy in patients with Lennox-Gastaut and Lennox-like syndromes","volume":"47","author":"Cukiert","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2022.04.004_bib0039","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1528-1167.2008.01740.x","article-title":"A blinded, crossover study of the efficacy of the ketogenic diet","volume":"50","author":"Freeman","year":"2009","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.seizure.2022.04.004_bib0040","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/epi.14540","article-title":"A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome","volume":"59","author":"Lagae","year":"2018","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2022.04.004_bib0041","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.pediatrneurol.2014.06.004","article-title":"Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome","volume":"51","author":"Kim","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2022.04.004_bib0042","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0883073814527162","article-title":"Use of the modified Atkins diet in Lennox Gastaut syndrome","volume":"30","author":"Sharma","year":"2015","journal-title":"J Child Neurol"},{"issue":"10","key":"10.1016\/j.seizure.2022.04.004_bib0043","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s12098-021-03668-x","article-title":"Pediatric epilepsy surgery: indications and evaluation","volume":"88","author":"Madaan","year":"2021","journal-title":"Ind J Pediatrics"},{"issue":"6","key":"10.1016\/j.seizure.2022.04.004_bib0044","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/epi.16546","article-title":"Cannabidiol efficacy and clobazam status: a systematic review and meta-analysis","volume":"61","author":"Lattanzi","year":"2020","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2022.04.004_bib0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ane.13351","article-title":"Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials","volume":"143","author":"Gunning","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"10.1016\/j.seizure.2022.04.004_bib0046","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003088-200443120-00001","article-title":"Pharmacokinetic interactions of topiramate","volume":"43","author":"Bialer","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.seizure.2022.04.004_bib0047","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1528-1167.2008.01665.x","article-title":"Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy","volume":"49","author":"Perucca","year":"2008","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2022.04.004_bib0048","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2165\/00003088-199733030-00004","article-title":"Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation","volume":"33","author":"Glue","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.seizure.2022.04.004_bib0049","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bcpt.13203","article-title":"Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients","volume":"125","author":"Koristkova","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.seizure.2022.04.004_bib0050","article-title":"Efficacy and prognosis of long-term, high-dose steroid therapy for Lennox-Gastaut syndrome","volume":"179","author":"Yang","year":"2021","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.seizure.2022.04.004_bib0051","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/epi4.12419","article-title":"Management practices for West syndrome in South Asia: a survey study and meta-analysis","volume":"5","author":"Madaan","year":"2020","journal-title":"Epilepsia open"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:02:45Z","timestamp":1761012165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":50,"alternative-id":["S1059131122000851"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.04.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term and long-term efficacy and safety of antiseizure medications in Lennox Gastaut syndrome: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}